Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Market Closed - Nasdaq
Other stock markets
 21:00:00 25/06/2024 BST 		5-day change 1st Jan Change
37.47 USD -3.92% Intraday chart for Apogee Therapeutics, Inc. +3.02% +34.11%
05-28 Apogee Therapeutics, Inc. Appoints Lisa Bollinger to Its Board of Directors CI
05-15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
APOGEE THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-3.92%+3.02%+34.11% - - 2.19B
Bearish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Charts Apogee Therapeutics, Inc.
  5. Comparison Chart